[P3] Poster Session III | WTTC20

Advanced Search

Session Details

Regular Session

[P3]Poster Session III

Wed. Aug 26, 2026 4:30 PM - 5:30 PM JST
Wed. Aug 26, 2026 7:30 AM - 8:30 AM UTC

Conference Rooms 3 & 4 (2F)

[P3-01]Developing Cerium Molecular Plating Techniques at SJSU

*Justice Wilkes¹, Brandon Barrios¹, Nicholas E. Esker¹ (1. San Jose State University (USA))

[P3-02]Resource-efficient production of Copper-64 using the solid-target and GMP-grade production of Cu-64 labeled Radiopharmaceuticals

*Waqas Rafique¹, Subhani Okarvi¹, Surendra Nakka¹, Yellareddy Yerram¹ (1. King Faisal Specialist Hospital & Research Center (Saudi Arabia))

[P3-03]Production and purification method of copper-61 from ^natZn targets made from pressed evaporation pellets

*Gustaf Forsberg^1,2, Klas Bratteby^1,2, Jonathan Ward Engle³, Thuy Amanda Tran^1,2, Jonathan Siikanen^1,2 (1. Karolinska Institute (Sweden), 2. Karolinska University Hospital (Sweden), 3. Univerity of Wisconsin (USA))

[P3-04]cGMP Production of Radiometal Solutions from Solid Targets at a University-scale Facility

*Aidan Bender¹, Brock Mower¹, Brandon Buckway^2,3, Jeffrey Yap^1,3 (1. Huntsman Cancer Institute (USA), 2. Sego Therapeutics (USA), 3. University of Utah (USA))

[P3-05]Validation of aluminium beam degradation for suppression of ⁸⁸Zr during solid-target ⁸⁹Zr production on an 18 MeV cyclotron

*Christoph Barkhausen^1,2, Damion Stimson², Arif Gulzar^1,2, Elizabeth Grenik², Carl Dixon², Donald Maillet², Kristofer Thurecht² (1. National Imaging Facility (Australia), 2. Australian Institute for Bioengineering and Nanotechnology, the University of Queensland (Australia))

[P3-06]Improvement of Dual Function Solid Target System

*Francisco Guerra Gomez¹, Masayoshi Nagayasu, Takumi Shimada, Kyohei Miyake, Takashi Oda, Tatsuya Kondo, Hiroaki Nakamura, Hiroki Higuchi, Toru Ishizuka (1. Sumitomo Heavy Industries, Ltd. (Japan))

[P3-07]N₂-H₂ gas target irradiated, flushed and rinsed

*Semi P. Helin¹, Jan-Olof Lill², Johan Rajander², Joakim M. K. Slotte², Olof Solin^1,2,3,4, Mikael Bergelin² (1. Turku PET Centre, Radiopharmaceutical Chemistry Laboratory, University of Turku (Finland), 2. Turku PET Centre, Accelerator Laboratory, Åbo Akademi University (Finland), 3. Department of Chemistry, University of Turku (Finland), 4. Turku PET Centre, Turku University Hospital, University of Turku (Finland))

[P3-08]Development of a Bi-209 target for At-211 production at the MC-50 cyclotron

*SangChul Mun¹, SeungPyo Hong¹, Seyoung Oh¹, KyoChul Lee¹ (1. Korea Institute of Radiological & Medical Sciences (Korea))

[P3-09]Calibration of a dose calibrator using in-house produced Ac-225

*Jun Ichinose¹, Yasushi Sato², Chihiro Shimodan², Kotaro Nagatsu¹ (1. National Institutes for Quantum Science and Technology (Japan), 2. National Institute of Advanced Industrial Science and Technology (Japan))

[P3-10]Safe handling and facility precautions for radium-226 targets

*Dale Schick-Martin¹, Matthew Hutcheson^1,2, Alisa R. Paterson¹, Jenelle MacKenzie¹, Evan T. Rand³, James Harrington³, Sohan Chouhan³, Kim Vu³, Graham Kent³, Bethany Johnsen³, Kevin McCaugherty⁴, Joseph Oliverio⁴ (1. Sylvia Fedoruk Canadian Centre for Nuclear Innovation (Canada), 2. University of Saskatchewan (Canada), 3. Canadian Nuclear Laboratories (Canada), 4. Actineer Inc. (Canada))

[P3-11]Advancing the production of copper radioisotopes, ⁶⁴Cu and ⁶⁷Cu, for copper-based radiopharmaceutical development using fusion neutrons

*Madeleine Woodward¹, Robert Annewandter¹, Han-Ying Liu¹, Owen Thomas¹, Tom Haywood¹, Tom Wallace-Smith¹, Talmon Firestone¹ (1. Astral Systems (UK))

[P3-12]OpenMC modelling of compact fusion-neutron targetry for medical isotope production of Cu-64, Cu-67, Sc-47 and I-131

*Robert Annewandter¹, Maddie Woodward¹, Talmon Firestone¹, Tom Wallace-Smith¹, Tom Haywood¹ (1. Astral Systems (UK))

[P3-13]Direct production cross-section of ^99mTc via ¹⁰⁰Mo(p,2n)^99mTc : Experimentally determined indirect contributions to ^99mTc as a function of proton energy and decay time

*Arjun Gopalakrishna¹, Suryanarayana S.V², B K Nayak², H Naik², A A Shanbhag², P Maletha², Kamal deep², D Sarkar², E T Mirgule², S C Sharma², P Mukherjee¹ (1. Board of Radiation and Isotope Technology, Department of Atomic Energy (India), 2. Bhabha Atomic Research Centre (India))

[P3-14]Multi-isotope production at the MC-50 cyclotron: current status and future expansion toward In- and Pb-based radionuclides

*seungPyo Hong¹ (1. KIRAMS (Korea))

[P3-15]Facility Expansion and Community-Driven Development of Nuclear Target Materials at ACF-Metals

*Constance Stoner¹, John P. Greene², Clause Müller-Gatermann², Mike Zach³, Dannie Steski⁴, Laura Bills¹, Clay Jolivet¹ (1. The Arizona Carbon Foil Co., Inc. dba: ACF-Metals (USA), 2. Argonne National Laboratory (USA), 3. WTID Designs, LLC (USA), 4. Brookhaven National Laboratory (USA))

[P3-16]Isotope Research and Production Capabilities at Brookhaven National Laboratory – Status Update

*Dmitri G Medvedev¹, Michael Chimes¹, Wilson Lin¹, Jonathan T Morrell¹, Michael D Phipps¹, Todd N Poe¹ (1. Isotope Research and Production Department, Brookhaven National Laboratory (USA))

[P3-17]Production and separation of ⁹⁷Tc from a ^natRu target and its isolation as an environmental radiotracer

*Manuel Luca BESMER¹, Megan R Keener¹, Brittany L Huffman¹, Kamil Chadirji-Martinez¹, Ellen M O'Brien¹, Christiaan Vermeulen¹, Stosh A Kozimor¹ (1. Los Alamos National Laboratory (USA))

[P3-18]Development of Ionic-Liquid-Impregnated Polymeric Resin for f-Block Separations in Nitric Acid Media

*Steven Joel Schultz¹, Michael Fassbender¹ (1. Los Alamos National Laboratory (USA))

[P3-19]Presentation of an Innovative Advanced Automated Module System to enhance the production of Astatine- 211 labelled Radiopharmaceuticals

*Dean Jolly¹, Antje Uhlending², Viplav Guptq³, Verena Hugenberg², Luis Metello¹ (1. CYCLOTech ATS – IsoPor Group, Portugal & USA (Portugal), 2. Heart and Diabetescenter NRW, Bad Oeynhausen (Germany), 3. German Cancer Research Center, Heidelberg (Germany))

[P3-20]Development of a Pd-103/Rh-103m generator for Auger emitter therapy

*Megan R Keener¹, Manuel L Besmer¹, Stosh A Kozimor¹, Ellen M. O'Brien¹, Christiaan Vermeulen¹ (1. Los Alamos National Laboratory (USA))

[P3-21]Comparative Study on Biodistribution of¹⁶¹Tb-Labeled Radioimmunoconjugate and Radiochemical Forms of Terbium-161 Potentially Present in Vivo

*Frantisek Trejtnar¹, Pavel Barta¹, Nikta Mehdizadeh¹, Martin Vlk², Marie Skalova², Tereza Janska², Jan Kozempel² (1. Charles University, Faculty of Pharmacy in Hradec Kralove (Czech Republic), 2. Czech Technical University in Prague, Faculty of Nuclear Sciences and Physical Engineering (Czech Republic))

[P3-22]Product stability evaluation of 18F-FDG produced using the SHI system in Chong Hua Hospital Mandaue

*Erwin Lorejas Navales¹, Raquel Louise Munsayac Espiritu¹ (1. Chong Hua Hospital Mandaue (Philippines))

Time Adjustment

Back to Category List